| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.35B | 17.34B | 16.28B | 15.45B | 14.21B | 12.19B |
| Gross Profit | 2.16B | 3.04B | 2.88B | 2.76B | 2.50B | 2.15B |
| EBITDA | 1.14B | 1.70B | 1.61B | 1.55B | 1.38B | 1.12B |
| Net Income | 765.56M | 1.19B | 1.08B | 1.12B | 942.73M | 748.51M |
Balance Sheet | ||||||
| Total Assets | 13.64B | 13.13B | 13.61B | 12.90B | 12.26B | 11.49B |
| Cash, Cash Equivalents and Short-Term Investments | 9.84B | 9.17B | 9.75B | 9.13B | 8.43B | 8.01B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 4.39B | 4.31B | 4.24B | 4.13B | 4.13B | 3.91B |
| Stockholders Equity | 9.25B | 8.82B | 9.37B | 8.77B | 8.12B | 7.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.34B | 1.24B | 1.14B | 902.66M | 982.15M |
| Operating Cash Flow | 0.00 | 1.36B | 1.25B | 1.19B | 942.62M | 984.46M |
| Investing Cash Flow | 0.00 | -23.31M | -17.48M | -68.35M | -39.97M | -29.45M |
| Financing Cash Flow | 0.00 | -1.92B | -615.90M | -424.21M | -482.01M | -364.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥22.43B | 19.31 | ― | 3.86% | 0.50% | 17.15% | |
77 Outperform | ¥28.02B | 12.67 | ― | 2.93% | 11.53% | 23.23% | |
76 Outperform | ― | 13.78 | ― | 2.53% | 16.13% | 62.27% | |
74 Outperform | ¥19.78B | 11.79 | ― | 2.40% | 21.57% | 129.44% | |
70 Outperform | ¥31.96B | 14.70 | ― | 2.83% | 4.51% | 75.35% | |
69 Neutral | ¥19.64B | 12.24 | ― | 0.82% | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |